Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-24 @ 1:03 PM
NCT ID:
NCT06174961
Eligibility Criteria:
Inclusion Criteria:
* Body weight 50 kg or more
* Body Mass Index 18.5-25 kg/m2
* Acceptance of not drinking alcohol for 24 hours before to 24 hours after dosing of study drug
* Acceptance of not performing physical activity for 24 hours before to 24 hours after dosing of study drug
* Signed informed consent form
Exclusion Criteria:
* History or sign of bleeding disorders
* History or sign of kidney disease
* History or sign of liver disease
* Average systolic blood pressure \<100 mmHg or \>140 mmHg and/or average diastolic blood pressure \<60 mmHg or \>90 mmHg (average of three measurements performed at screening).
* Daily pharmaceutical treatment
* Contraindication to increased levels of physical activity (10)
* Smoking or other regular use of any form of nicotine products during the study period and the previous 3 months.
* Current or prior participation (within 3 months before screening) in other clinical trials that might affect the results of this study (judged by the investigator).
* Previous treatment with heparins
* Low levels of anti-thrombin (P-antitrombin(enz.) \<0,80 kIU/L)
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT06174961
Study Brief:
Protocol Section:
NCT06174961